Literature DB >> 22749846

Characterization of retinal expression of vascular cell adhesion molecule (VCAM-1) during experimental autoimmune uveitis.

M Makhoul1, R Dewispelaere, L J Relvas, V Elmaleh, L Caspers, C Bruyns, F Willermain.   

Abstract

Leukocyte adhesion to the blood retinal barrier is a critical step in the pathogenesis of non-infectious uveitis and is mediated in part through the induction of adhesion molecules on retinal cells. Here, we have investigated the retinal expression of Vascular Cell Adhesion Molecule 1 (VCAM-1) in mouse experimental models of non-infectious uveitis. For each eyes, a histological score was given, and the expression of VCAM-1 analyzed by immunohistology. Co-labellings for GFAP, endoglin, aquaporin 4 and recoverin were also performed in order to determine which cell type expressed VCAM-1. In low grade uveitis, obtained after adoptive transfer of semi-purified autoreactive lymphocytes, VCAM-1 was only punctually expressed in the internal limiting membrane and epithelial cells of the ciliary body. Using the same adoptive transfer protocol, we found that, in correlation with disease severity, the staining extended to all internal limiting membranes, vasculitis lesions, Müller cell extensions, outer limiting membranes and RPE cells. VCAM-1 expression in the inner limiting membrane and Müller cell extensions co-stained with GFAP expression. In vasculitis lesions, VCAM-1 co-localized with either GFAP and endoglin expression. The labeling in the outer limiting membrane, did not exactly co-stained with AQ4 (Müller cells marker) or recoverin (photoreceptor marker) and the nature of this expression remained unexplained. Finally, VCAM-1 expression was also analyzed in classical experimental autoimmune uveitis eyes, and a similar pattern of expression was found. In conclusion VCAM-1 is expressed on all blood retinal barrier cells during experimental non-infectious uveitis and might thus play an important role in inflammatory cell recruitment during disease development.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22749846     DOI: 10.1016/j.exer.2012.05.012

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  7 in total

1.  Comprehensive analysis of a mouse model of spontaneous uveoretinitis using single-cell RNA sequencing.

Authors:  Jacob S Heng; Sean F Hackett; Genevieve L Stein-O'Brien; Briana L Winer; John Williams; Loyal A Goff; Jeremy Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-16       Impact factor: 11.205

2.  Characterization of mouse ocular response to a 35-day spaceflight mission: Evidence of blood-retinal barrier disruption and ocular adaptations.

Authors:  Xiao W Mao; Nina C Nishiyama; Stephanie D Byrum; Seta Stanbouly; Tamako Jones; Alyson Drew; Vijayalakshmi Sridharan; Marjan Boerma; Alan J Tackett; David Zawieja; Jeffrey S Willey; Michael Delp; Michael J Pecaut
Journal:  Sci Rep       Date:  2019-06-03       Impact factor: 4.379

3.  Small-molecule antagonist of VLA-4 (GW559090) attenuated neuro-inflammation by targeting Th17 cell trafficking across the blood-retinal barrier in experimental autoimmune uveitis.

Authors:  Yi Hsing Chen; Malihe Eskandarpour; Xiaozhe Zhang; Grazyna Galatowicz; John Greenwood; Sue Lightman; Virginia Calder
Journal:  J Neuroinflammation       Date:  2021-02-18       Impact factor: 8.322

4.  Thermostable small-molecule inhibitor of angiogenesis and vascular permeability that suppresses a pERK-FosB/ΔFosB-VCAM-1 axis.

Authors:  Yue Li; Ahmad M N Alhendi; Mei-Chun Yeh; Mina Elahy; Fernando S Santiago; Nandan P Deshpande; Ben Wu; Enoch Chan; Shafqat Inam; Leonel Prado-Lourenco; Jessica Marchand; Rohan D Joyce; Lorna E Wilkinson-White; Mark J Raftery; Meidong Zhu; Samuel J Adamson; François Barnat; Karen Viaud-Quentric; Jim Sockler; Joel P Mackay; Andrew Chang; Paul Mitchell; Sebastian M Marcuccio; Levon M Khachigian
Journal:  Sci Adv       Date:  2020-07-29       Impact factor: 14.136

5.  Retinal endothelial cell phenotypic modifications during experimental autoimmune uveitis: a transcriptomic approach.

Authors:  Deborah A Lipski; Vincent Foucart; Rémi Dewispelaere; Laure E Caspers; Matthieu Defrance; Catherine Bruyns; François Willermain
Journal:  BMC Ophthalmol       Date:  2020-03-17       Impact factor: 2.209

6.  Pathogenic TNF-α drives peripheral nerve inflammation in an Aire-deficient model of autoimmunity.

Authors:  Yan Wang; Lily Guo; Xihui Yin; Ethan C McCarthy; Mandy I Cheng; Aline T Hoang; Ho-Chung Chen; Anushi Y Patel; Denise Allard Trout; Erin Xu; Natalie Yakobian; Willy Hugo; James F Howard; Katherine M Sheu; Alexander Hoffmann; Melissa G Lechner; Maureen A Su
Journal:  Proc Natl Acad Sci U S A       Date:  2022-01-25       Impact factor: 11.205

7.  Low-Dose Recombinant Adeno-Associated Virus-Mediated Inhibition of Vascular Endothelial Growth Factor Can Treat Neovascular Pathologies Without Inducing Retinal Vasculitis.

Authors:  Shun-Yun Cheng; Yongwen Luo; Anneliese Malachi; Jihye Ko; Qin Su; Jun Xie; Bo Tian; Haijiang Lin; Xiao Ke; Qiang Zheng; Phillip W L Tai; Guangping Gao; Claudio Punzo
Journal:  Hum Gene Ther       Date:  2021-07       Impact factor: 5.695

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.